A devastating indictment. That’s what Dr. Daniel Carlat – on his blog – called yesterday’s piece in the Milwaukee Journal Sentinel, “Drug firms’ cash skews doctor classes: Company-funded UW courses often favor medicine, leave out side effects.”
I’m late in weighing in on this, so I’ll just refer you to Carlat’s analysis.
But I will add this: somehow that little paper in Milwaukee continues to publish top-notch tough investigative health care journalism and their readers should appreciate what they’re getting while they’re still getting it. This story was more than 2,500 words of important news – not the usual 300 word drivel trumpeting breakthroughs from the medical journals. Carlat said “Occasionally, a piece of investigative journalism sets into motion processes that strike corrupt business practices at their core. …it will become required reading for all those involved in health care policy.”
Opinions on other issues in news, journals, PR, advertising, marketing
We’ve written about the hype of liquid biopsies for years (see link in comment below). And now this…. https://www.statnews.com/2022/01/12/medicare-shouldnt-cover-liquid-biopsies-early-cancer-detection/
Case counts still matter. “(There) are stories that may not be told adequately if only hospitalizations and deaths are emphasized.” @garyschwitzer interviewed by @dbauder of @AP. https://apnews.com/article/omicron-changing-news-outlets-covid-data-da9272f7c4c8a109c3bfb56bed9e9c76
My friend Gary @garyschwitzer wrote to his city council representative in a Minnesota town about a Viva Las Vegas event scheduled for January.
The response he got seems to perfectly capture where we are now.
https://www.healthnewsreview.org/2021/12/2021-ends-with-covid-craziness-in-sports-and-politics/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
John Butler
April 1, 2009 at 8:34 pmThe article makes this type of marketing practice seem like a new discovery. It has been around for awhile. News is… transparency, I believe has remarkably improved in recent years. Most institutions are extremely sensitive to bias- in contrast to the past.
I think this it is important for the public to know that a huge amount of pharma marketing is used to influence physician practices. Journal ads, “detailing” literature, pencils and pens- its everywhere.
However, what was expected and acceptable 10-20 years ago, has dramatically diminished in my opinion.
I just returned from a week long CME conference presented by Mayo, and each presenter preceded his presentation with financial disclosures- a minority had them. But, there was transparency.
This is in extreme contrast to past practices.
I think the news is that disclosure and transparency is headed in the right direction.
John Butler MD
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like